Skip to main content

Table 2 Summary of in vitro studies on tenogenic differentiation by growth factors in horse

From: Strategies of tenogenic differentiation of equine stem cells for tendon repair: current status and challenges

Growth factor

Concentration

Other modification

Cell source

Outcome

Reference

TGFB3

20 ng/ml

2D and 3D cultures

Tenocytes and ESCs

Unlike tenocytes, ESCs upregulated tendon markers in 2D culture and showed synergic effect with TGFB3 and 3D; no cartilage or bone tissue deposition

[41, 62]

TGFB3

20 ng/ml

3D collagen gel

IPS

Reduced expression of tendon-related marker of iPSCs in 3D versus 2D culture

[5]

BMP12

50 ng/ml

 

AF-MSCs

Elongated and spindle-shaped; expressed TNMD and DCN genes

[63]

BMP12

50 ng/ml

 

BM-MSCs

Elongated tenocyte-like phenotype; expressed TNMD and DCN genes

[64]

BMP12

50 ng/ml

 

UCB-MSCs

Expression of SCX, MKX, TNM, COL1, and DCN by RT-PCR; expression of protein TNM, DCN

[65]

TGFB3, EGF2, bFGF2, IGF-1

10 ng/ml

LLLT

PB-MSCs

Supplementation with bFGF2 and TGFB3 upregulated expression of EGR1, and DCN; increased TNC with LLLT

[66]

PDGF-BB, IGF-1, bFGF, SDF-1 α, and GDF-5

5, 50, 5, 50 and 100 ng/ml respectively

Scaffold

Tenocytes

Effect of pairing IGF-1, GDF-5 rescue the tenocyte phenotype and gene expression profiles and driving proliferation

[67]

TGFB1, IGF-1, insulin

10 ng/ml and 50 ng/ml

2D and 3D cultures

Tenocyte

Pro-tenogenic effect with 3D culture system treated with GFs

[40]

GDF5, GDF6 and GDF7

10 ng/ml and 100 ng/ml

Strain stimulation; oxygen tension

AD-MSC

Expression of tendon-relevant genes were higher with an oxygen tension of 21%, tensile stimulation and supplementation with GDF5 or GDF 7

[68]

IGF-1

100 ng/ml

Acellular tendon matrix

BM-MSCs and TDSCs

COL and GAG syntheses were higher in TDSCs; no significant difference was observed in the expression of COL1, COL3, and COMP between BM-MSCs and TDSCs

[69]

TGFB3

2.5 ng/ml

Treated with Gremlin and SOST; nanofiber scaffold

ASCs

Increased tenogenic markers; decreased osteo-chondrogenic markers treated with T/G/S on nanofiber scaffold

Our unpublished data

  1. Abbreviations: TGF-β transforming growth factor, BMP bone morphogenetic protein, EGF epidermal growth factor, bFGF fibroblast growth factor, IGF-1 insulin-like growth factor, PDGF-BB platelet-derived growth factor-BB, GDF growth and differentiation factor, SDF-1 stromal cell-derived factor-1, EGR1 early growth response protein 1, DCN decorin, COL3A1 collagen type III, COL1A1 collagen type I, TNMD tenomodulin, T/G/S TGFB3/Gremlin/SOST, LLLT low-level laser therapy